Evaluation of the neurotoxic potential of N,N-dimethylamphetamine: an illicit analog of methamphetamine

George Ricaurte, L. E. DeLanney, I. Irwin, J. M. Witkin, J. L. Katz, J. W. Langston

Research output: Contribution to journalArticle

Abstract

The purpose of this study was to evaluate the neurotoxic potential of N,N-dimethylamphetamine (N,N-DMA), a controlled substance analog that has recently appeared on the illicit drug market, and compare it to that of methamphetamine, a structurally related drug with known dopaminergic and serotonergic neurotoxic activity. Like methamphetamine, N,N-DMA induced degeneration of nerve terminals in the mouse striatum, but did not produce cell loss in the pars compacta of the substantia nigra. The dopamine-depleting effects of N,N-DMA were approximately one-eighth of those of methamphetamine. Assessment of N,N-DMA's effects on serotonergic neurons showed that it did not produce a long-lasting depletion of serotonin in either the mouse or rat brain. By contrast, equivalent doses of methamphetamine depleted serotonin in the rat brain by 82%. These results indicate that N,N-DMA, the N-methylated analog of methamphetamine, is considerably less potent than its parent compound both as a dopaminergic and serotonergic neurotoxin, and raise the question of whether or not it may be possible to dissociate the neurotoxic effects of methamphetamine from its reinforcing actions by means of N-methylation. Safety of N,N-DMA in humans remains to be investigated.

Original languageEnglish (US)
Pages (from-to)301-306
Number of pages6
JournalBrain Research
Volume490
Issue number2
DOIs
StatePublished - Jun 26 1989

Fingerprint

Methamphetamine
Serotonin
Controlled Substances
Serotonergic Neurons
Nerve Degeneration
Dopamine Agents
Neurotoxins
Brain
Street Drugs
Methylation
dimethylamphetamine
Safety
Pharmaceutical Preparations

Keywords

  • Dopamine
  • Drug abuse
  • Methamphetamine
  • Neurotoxicity
  • Serotonin

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Evaluation of the neurotoxic potential of N,N-dimethylamphetamine : an illicit analog of methamphetamine. / Ricaurte, George; DeLanney, L. E.; Irwin, I.; Witkin, J. M.; Katz, J. L.; Langston, J. W.

In: Brain Research, Vol. 490, No. 2, 26.06.1989, p. 301-306.

Research output: Contribution to journalArticle

Ricaurte, George ; DeLanney, L. E. ; Irwin, I. ; Witkin, J. M. ; Katz, J. L. ; Langston, J. W. / Evaluation of the neurotoxic potential of N,N-dimethylamphetamine : an illicit analog of methamphetamine. In: Brain Research. 1989 ; Vol. 490, No. 2. pp. 301-306.
@article{0ccd3f8201034e1fa8e4b7a984b79e0a,
title = "Evaluation of the neurotoxic potential of N,N-dimethylamphetamine: an illicit analog of methamphetamine",
abstract = "The purpose of this study was to evaluate the neurotoxic potential of N,N-dimethylamphetamine (N,N-DMA), a controlled substance analog that has recently appeared on the illicit drug market, and compare it to that of methamphetamine, a structurally related drug with known dopaminergic and serotonergic neurotoxic activity. Like methamphetamine, N,N-DMA induced degeneration of nerve terminals in the mouse striatum, but did not produce cell loss in the pars compacta of the substantia nigra. The dopamine-depleting effects of N,N-DMA were approximately one-eighth of those of methamphetamine. Assessment of N,N-DMA's effects on serotonergic neurons showed that it did not produce a long-lasting depletion of serotonin in either the mouse or rat brain. By contrast, equivalent doses of methamphetamine depleted serotonin in the rat brain by 82{\%}. These results indicate that N,N-DMA, the N-methylated analog of methamphetamine, is considerably less potent than its parent compound both as a dopaminergic and serotonergic neurotoxin, and raise the question of whether or not it may be possible to dissociate the neurotoxic effects of methamphetamine from its reinforcing actions by means of N-methylation. Safety of N,N-DMA in humans remains to be investigated.",
keywords = "Dopamine, Drug abuse, Methamphetamine, Neurotoxicity, Serotonin",
author = "George Ricaurte and DeLanney, {L. E.} and I. Irwin and Witkin, {J. M.} and Katz, {J. L.} and Langston, {J. W.}",
year = "1989",
month = "6",
day = "26",
doi = "10.1016/0006-8993(89)90247-3",
language = "English (US)",
volume = "490",
pages = "301--306",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Evaluation of the neurotoxic potential of N,N-dimethylamphetamine

T2 - an illicit analog of methamphetamine

AU - Ricaurte, George

AU - DeLanney, L. E.

AU - Irwin, I.

AU - Witkin, J. M.

AU - Katz, J. L.

AU - Langston, J. W.

PY - 1989/6/26

Y1 - 1989/6/26

N2 - The purpose of this study was to evaluate the neurotoxic potential of N,N-dimethylamphetamine (N,N-DMA), a controlled substance analog that has recently appeared on the illicit drug market, and compare it to that of methamphetamine, a structurally related drug with known dopaminergic and serotonergic neurotoxic activity. Like methamphetamine, N,N-DMA induced degeneration of nerve terminals in the mouse striatum, but did not produce cell loss in the pars compacta of the substantia nigra. The dopamine-depleting effects of N,N-DMA were approximately one-eighth of those of methamphetamine. Assessment of N,N-DMA's effects on serotonergic neurons showed that it did not produce a long-lasting depletion of serotonin in either the mouse or rat brain. By contrast, equivalent doses of methamphetamine depleted serotonin in the rat brain by 82%. These results indicate that N,N-DMA, the N-methylated analog of methamphetamine, is considerably less potent than its parent compound both as a dopaminergic and serotonergic neurotoxin, and raise the question of whether or not it may be possible to dissociate the neurotoxic effects of methamphetamine from its reinforcing actions by means of N-methylation. Safety of N,N-DMA in humans remains to be investigated.

AB - The purpose of this study was to evaluate the neurotoxic potential of N,N-dimethylamphetamine (N,N-DMA), a controlled substance analog that has recently appeared on the illicit drug market, and compare it to that of methamphetamine, a structurally related drug with known dopaminergic and serotonergic neurotoxic activity. Like methamphetamine, N,N-DMA induced degeneration of nerve terminals in the mouse striatum, but did not produce cell loss in the pars compacta of the substantia nigra. The dopamine-depleting effects of N,N-DMA were approximately one-eighth of those of methamphetamine. Assessment of N,N-DMA's effects on serotonergic neurons showed that it did not produce a long-lasting depletion of serotonin in either the mouse or rat brain. By contrast, equivalent doses of methamphetamine depleted serotonin in the rat brain by 82%. These results indicate that N,N-DMA, the N-methylated analog of methamphetamine, is considerably less potent than its parent compound both as a dopaminergic and serotonergic neurotoxin, and raise the question of whether or not it may be possible to dissociate the neurotoxic effects of methamphetamine from its reinforcing actions by means of N-methylation. Safety of N,N-DMA in humans remains to be investigated.

KW - Dopamine

KW - Drug abuse

KW - Methamphetamine

KW - Neurotoxicity

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=0024348380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024348380&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(89)90247-3

DO - 10.1016/0006-8993(89)90247-3

M3 - Article

C2 - 2765865

AN - SCOPUS:0024348380

VL - 490

SP - 301

EP - 306

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -